Friday, October 20, 2006

Merck, Schering-Plough Shares Climb

Article in today's Washington Post -- Merck, Schering-Plough Shares Climb, by Linda Johnson.  The article notes that "Merck . . . said it can now reasonably estimate its Vioxx costs through 2008 and reserved an additional $598 million for future defense costs, on top of the $970 million previously set aside. But the number of Vioxx lawsuits has now topped 24,000, and an additional 15,000 potential plaintiffs have entered agreements temporarily suspending the time to sue."


Vioxx | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Merck, Schering-Plough Shares Climb:


Post a comment